Concise review

Diabetes, the bone marrow niche, and impaired vascular regeneration

Gian Paolo Fadini, Francesca Ferraro, Federico Quaini, Takayuki Asahara, Paolo Madeddu

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Diabetes mellitus is a global health problem that results in multiorgan complications leading to high morbidity and mortality. Until recently, the effects of diabetes and hyperglycemia on the bone marrow microenvironment-a site where multiple organ systems converge and communicate-have been underappreciated. However, several new studies in mice, rats, and humans reveal that diabetes leads to multiple bone marrow microenvironmental defects, such as small vessel disease (microangiopathy), nerve terminal pauperization (neuropathy), and impaired stem cell mobilization (mobilopathy). The discovery that diabetes involves bone marrow-derived progenitors implicated in maintaining cardiovascular homeostasis has been proposed as a bridging mechanism between microand macroangiopathy in distant organs. Herein, wereview the physiological and molecular bone marrow abnormalities associated with diabetes and discuss how bone marrow dysfunction represents a potential root for the development of the multiorgan failure characteristic of advanced diabetes. The notion of diabetes as a bone marrow and stem cell disease opens new avenues for therapeutic interventions ultimately aimed at improving the outcome of diabetic patients.

Original languageEnglish
Pages (from-to)949-957
Number of pages9
JournalStem cells translational medicine
Volume3
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Blood Vessels
Regeneration
Bone Marrow
Hematopoietic Stem Cell Mobilization
Bone Marrow Cells
Hyperglycemia
Diabetes Mellitus
Homeostasis
Stem Cells
Morbidity
Mortality
Therapeutics

Keywords

  • Complications
  • Regeneration
  • Stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Concise review : Diabetes, the bone marrow niche, and impaired vascular regeneration. / Fadini, Gian Paolo; Ferraro, Francesca; Quaini, Federico; Asahara, Takayuki; Madeddu, Paolo.

In: Stem cells translational medicine, Vol. 3, No. 8, 2014, p. 949-957.

Research output: Contribution to journalArticle

Fadini, Gian Paolo ; Ferraro, Francesca ; Quaini, Federico ; Asahara, Takayuki ; Madeddu, Paolo. / Concise review : Diabetes, the bone marrow niche, and impaired vascular regeneration. In: Stem cells translational medicine. 2014 ; Vol. 3, No. 8. pp. 949-957.
@article{762706355542425fb115d249b8f22b8f,
title = "Concise review: Diabetes, the bone marrow niche, and impaired vascular regeneration",
abstract = "Diabetes mellitus is a global health problem that results in multiorgan complications leading to high morbidity and mortality. Until recently, the effects of diabetes and hyperglycemia on the bone marrow microenvironment-a site where multiple organ systems converge and communicate-have been underappreciated. However, several new studies in mice, rats, and humans reveal that diabetes leads to multiple bone marrow microenvironmental defects, such as small vessel disease (microangiopathy), nerve terminal pauperization (neuropathy), and impaired stem cell mobilization (mobilopathy). The discovery that diabetes involves bone marrow-derived progenitors implicated in maintaining cardiovascular homeostasis has been proposed as a bridging mechanism between microand macroangiopathy in distant organs. Herein, wereview the physiological and molecular bone marrow abnormalities associated with diabetes and discuss how bone marrow dysfunction represents a potential root for the development of the multiorgan failure characteristic of advanced diabetes. The notion of diabetes as a bone marrow and stem cell disease opens new avenues for therapeutic interventions ultimately aimed at improving the outcome of diabetic patients.",
keywords = "Complications, Regeneration, Stem cells",
author = "Fadini, {Gian Paolo} and Francesca Ferraro and Federico Quaini and Takayuki Asahara and Paolo Madeddu",
year = "2014",
doi = "10.5966/sctm.2014-0052",
language = "English",
volume = "3",
pages = "949--957",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "8",

}

TY - JOUR

T1 - Concise review

T2 - Diabetes, the bone marrow niche, and impaired vascular regeneration

AU - Fadini, Gian Paolo

AU - Ferraro, Francesca

AU - Quaini, Federico

AU - Asahara, Takayuki

AU - Madeddu, Paolo

PY - 2014

Y1 - 2014

N2 - Diabetes mellitus is a global health problem that results in multiorgan complications leading to high morbidity and mortality. Until recently, the effects of diabetes and hyperglycemia on the bone marrow microenvironment-a site where multiple organ systems converge and communicate-have been underappreciated. However, several new studies in mice, rats, and humans reveal that diabetes leads to multiple bone marrow microenvironmental defects, such as small vessel disease (microangiopathy), nerve terminal pauperization (neuropathy), and impaired stem cell mobilization (mobilopathy). The discovery that diabetes involves bone marrow-derived progenitors implicated in maintaining cardiovascular homeostasis has been proposed as a bridging mechanism between microand macroangiopathy in distant organs. Herein, wereview the physiological and molecular bone marrow abnormalities associated with diabetes and discuss how bone marrow dysfunction represents a potential root for the development of the multiorgan failure characteristic of advanced diabetes. The notion of diabetes as a bone marrow and stem cell disease opens new avenues for therapeutic interventions ultimately aimed at improving the outcome of diabetic patients.

AB - Diabetes mellitus is a global health problem that results in multiorgan complications leading to high morbidity and mortality. Until recently, the effects of diabetes and hyperglycemia on the bone marrow microenvironment-a site where multiple organ systems converge and communicate-have been underappreciated. However, several new studies in mice, rats, and humans reveal that diabetes leads to multiple bone marrow microenvironmental defects, such as small vessel disease (microangiopathy), nerve terminal pauperization (neuropathy), and impaired stem cell mobilization (mobilopathy). The discovery that diabetes involves bone marrow-derived progenitors implicated in maintaining cardiovascular homeostasis has been proposed as a bridging mechanism between microand macroangiopathy in distant organs. Herein, wereview the physiological and molecular bone marrow abnormalities associated with diabetes and discuss how bone marrow dysfunction represents a potential root for the development of the multiorgan failure characteristic of advanced diabetes. The notion of diabetes as a bone marrow and stem cell disease opens new avenues for therapeutic interventions ultimately aimed at improving the outcome of diabetic patients.

KW - Complications

KW - Regeneration

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84905509926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905509926&partnerID=8YFLogxK

U2 - 10.5966/sctm.2014-0052

DO - 10.5966/sctm.2014-0052

M3 - Article

VL - 3

SP - 949

EP - 957

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 8

ER -